Related references
Note: Only part of the references are listed.KISS1 Methylation and Expression as Tumor Stratification Biomarkers and Clinical Outcome Prognosticators for Bladder Cancer Patients
Virginia Cebrian et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine
Pi-Che Chen et al.
BMC MEDICAL GENOMICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Association of secondhand smoke exposures with DNA methylation in bladder carcinomas
Charlotte S. Wilhelm-Benartzi et al.
CANCER CAUSES & CONTROL (2011)
Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments
Woonbok Chung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Aberrant Methylation of RARβ2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer
Sanaa Eissa et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
Naotaka Nishiyama et al.
CARCINOGENESIS (2011)
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Thomas Reinert et al.
CLINICAL CANCER RESEARCH (2011)
Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Guerin Response in Patients With T1G3 High-Risk Bladder Tumours
Miriam Agundez et al.
EUROPEAN UROLOGY (2011)
Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events
Reza R. Serizawa et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder
Yanhua Xuan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
DNA Methylation Array Analysis Identifies Profiles of Blood-Derived DNA Methylation Associated With Bladder Cancer
Carmen J. Marsit et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer
Maria Jose Cabello et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
Celine Vallot et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study
Serena Vinci et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
Erika M. Wolff et al.
CANCER RESEARCH (2010)
Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage
Naotaka Nishiyama et al.
CANCER SCIENCE (2010)
DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer
C. S. Wilhelm-Benartzi et al.
CARCINOGENESIS (2010)
Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
Vera L. Costa et al.
CLINICAL CANCER RESEARCH (2010)
Epigenetic regulation of Wnt signaling pathway in urological cancer
Vera L. Costa et al.
EPIGENETICS (2010)
Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
Sonata Jarmalaite et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Custom-Designed MLPA Using Multiple Short Synthetic Probes Application to Methylation Analysis of Five Promoter CpG Islands in Tumor and Urine Specimens from Patients with Bladder Cancer
Reza R. Serizawa et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Low Frequency of Epigenetic Events in Urothelial Tumors in Young Patients
Helen C. Owen et al.
JOURNAL OF UROLOGY (2010)
Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder Cancer
Miguel Alvarez-Mugica et al.
JOURNAL OF UROLOGY (2010)
Differential Protein Expression Profiling by iTRAQ-Two-dimensional LC-MS/MS of Human Bladder Cancer EJ138 Cells Transfected with the Metastasis Suppressor KiSS-1 Gene
Isabel Ruppen et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
CpG islands influence chromatin structure via the CpG-binding protein Cfp1
John P. Thomson et al.
NATURE (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
Identification of Methylated Genes Associated with Aggressive Bladder Cancer
Carmen J. Marsit et al.
PLOS ONE (2010)
Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine
Hui-Hui Lin et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract
Veronique Phe et al.
BJU INTERNATIONAL (2009)
Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
Isabelle Renard et al.
EUROPEAN UROLOGY (2009)
Epigenetic biomarkers in urothelial bladder cancer
Wun-Jae Kim et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
MS-qFRET: A quantum dot-based method for analysis of DNA methylation
Vasudev J. Bailey et al.
GENOME RESEARCH (2009)
BAMBI gene is epigenetically silenced in subset of high-grade bladder cancer
Sann Sanda Khin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Over- and under-expressed microRNAs in human colorectal cancer
Kazuo Motoyama et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Epigenetic markers as promising prognosticators for bladder cancer
Young Kyoon Kim et al.
INTERNATIONAL JOURNAL OF UROLOGY (2009)
Hypermethylated SFRP1, but none of other nine genes informative for western countries, is valuable for bladder cancer detection in mainland China
Jinfeng Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Human DNA methylomes at base resolution show widespread epigenomic differences
Ryan Lister et al.
NATURE (2009)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
Akiko Doi et al.
NATURE GENETICS (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Developmental programming of CpG island methylation profiles in the human genome
Ravid Straussman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol
Francesca Malentacchi et al.
NUCLEIC ACIDS RESEARCH (2009)
Insulin Gene Expression Is Regulated by DNA Methylation
Akio Kuroda et al.
PLOS ONE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis
Morgan Roupret et al.
BJU INTERNATIONAL (2008)
Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours
Olaf J. C. Hellwinkel et al.
BJU INTERNATIONAL (2008)
DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection
Priscilla D. Negraes et al.
BMC CANCER (2008)
Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer
Mariana Brait et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking
Erika M. Wolff et al.
CANCER RESEARCH (2008)
Identification of PMF1 Methylation in Association with Bladder Cancer Progression
Ainel Aleman et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer
Olusola Y. Dokun et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Epigenetics in bladder cancer
Hideki Enokida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Discovery of myopodin methylation in bladder cancer
V. Cebrian et al.
JOURNAL OF PATHOLOGY (2008)
Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor
Eun-Jung Kim et al.
JOURNAL OF UROLOGY (2008)
Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer
Mohammad Obaidul Hoque et al.
JOURNAL OF UROLOGY (2008)
Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder
Phillip H. Abbosh et al.
MODERN PATHOLOGY (2008)
DNA methylation landscapes: provocative insights from epigenomics
Miho M. Suzuki et al.
NATURE REVIEWS GENETICS (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer
Sonata Jarmalaite et al.
ONCOLOGY (2008)
Comparative promoter methylation analysis of p53 target genes in urogenital cancers
Frank Christoph et al.
UROLOGIA INTERNATIONALIS (2008)
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
A. Aleman et al.
BRITISH JOURNAL OF CANCER (2008)
A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer
Jian Yu et al.
CLINICAL CANCER RESEARCH (2007)
Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase
W-T Chen et al.
HISTOPATHOLOGY (2007)
The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer
Mark L. Gonzalgo et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller
HUMAN MOLECULAR GENETICS (2007)
Promoter hypermethylation identifies progression risk in bladder cancer
David R. Yates et al.
CLINICAL CANCER RESEARCH (2007)
Gene body-specific methylation on the active X chromosome
Asaf Hellman et al.
SCIENCE (2007)
Molecular alterations associated with bladder cancer progression
Marta Sanchez-Carbayo et al.
SEMINARS IN ONCOLOGY (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer
F. Christoph et al.
BRITISH JOURNAL OF CANCER (2006)
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder
Frank Christoph et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Methylation profiling of urothelial carcinoma in bladder biopsy and urine
Robert T. Pu et al.
ACTA CYTOLOGICA (2006)
Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder
Andriy O. Yurakh et al.
EUROPEAN UROLOGY (2006)
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Mohammad Obaidul Hoque et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma
D. Dhawan et al.
JOURNAL OF PATHOLOGY (2006)
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls
DR Yates et al.
ONCOGENE (2006)
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
K Kawamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Carcinogen exposure and gene promoter hypermethylation in bladder cancer
CJ Marsit et al.
CARCINOGENESIS (2006)
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma
MG Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2005)
RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors
WJ Kim et al.
CANCER RESEARCH (2005)
Mechanisms of disease: genetic and EPIGENETIC alterations that drive bladder cancer
EM Wolff et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer
CJ Marsit et al.
CANCER RESEARCH (2005)
Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype
EJ Chapman et al.
CLINICAL CANCER RESEARCH (2005)
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
JWF Catto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Multiple mechanisms downregulate CDKN1C in human bladder cancer
MJ Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells
N Hattori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel
E Dulaimi et al.
CLINICAL CANCER RESEARCH (2004)
Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes
UG Sathyanarayana et al.
CANCER RESEARCH (2004)
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients
MG Friedrich et al.
CLINICAL CANCER RESEARCH (2004)
An evaluation of new criteria for CpG islands in the human genome as gene markers
Y Wang et al.
BIOINFORMATICS (2004)
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types
N Shivapurkar et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Applications of array technology:: identification of molecular targets in bladder cancer
M Sánchez-Carbayo et al.
BRITISH JOURNAL OF CANCER (2003)
Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors
G Dominguez et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome
M Sanchez-Carbayo et al.
ONCOGENE (2003)
Genetic alterations of P16INK4A and P14ARF genes in human bladder cancer
LL Chang et al.
JOURNAL OF UROLOGY (2003)
Chromosomal instability and tumors promoted by DNA hypomethylation
A Eden et al.
SCIENCE (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ
Y Horikawa et al.
JOURNAL OF UROLOGY (2003)
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
MF Robert et al.
NATURE GENETICS (2003)
Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer
M Sanchez-Carbayo
CLINICAL CHEMISTRY (2003)
Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder
T Nakagawa et al.
JOURNAL OF UROLOGY (2003)
Assessing the use of p16INK4a promoter gene methylation in serum for detection of bladder cancer
MT Valenzuela et al.
EUROPEAN UROLOGY (2002)
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer
LA Ribeiro et al.
MOLECULAR CARCINOGENESIS (2002)
Role for DNA methylation in the control of cell type-specific maspin expression
BW Futscher et al.
NATURE GENETICS (2002)
Identification of a novel Ras-regulated proapoptotic pathway
A Khokhlatchev et al.
CURRENT BIOLOGY (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals
DM Bornman et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer
T Habuchi et al.
ONCOGENE (2001)
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder
AR Florl et al.
LABORATORY INVESTIGATION (2000)
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
DM Scolnick et al.
NATURE (2000)
Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1,3a and 3b during the G0/G1 to S phase transition in normal and tumor cells
KD Robertson et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
